Healing & Recovery / Published Sep 8, 2026 / Reviewed Sep 27, 2026 / 8 min read
GLOW vs KLOW vs Wolverine: What Is in Each Stack and What the Evidence Says, Ingredient by Ingredient
Written by Aaron CuhaReviewed Sep 27, 2026
The three most-searched peptide blends of 2026 in plain English: what is in Wolverine, GLOW and KLOW, what happened when people used each ingredient, the shelf-life problem nobody mentions, and why no study has ever tested any of the blends.
Key takeaways
- Wolverine is BPC-157 plus TB-500. GLOW adds GHK-Cu. KLOW adds KPV to GLOW. All three are blends made up by sellers, not products anyone has studied.
- No published study, in animals or people, has tested any of the three blends.
- The ingredients are much less alike than the ads suggest. Thymosin beta-4, the full protein TB-500 comes from, has been tested in more than 1,600 people, and the biggest study failed. GHK-Cu has two studies in people, and neither beat a cream with nothing in it on anything a doctor could measure. BPC-157 has three small reports from one clinic, with nobody to compare against. KPV has never been given to a person in any study.
- None of the four is approved by the FDA. Three of them went through the July 2026 FDA panel vote on pharmacy-made drugs.
- By weight, GHK-Cu is roughly 60 to 70 percent of a GLOW or KLOW vial. Using it for a long time adds up to a real amount of copper.
- Putting an acidic, copper-carrying peptide in the same vial as two other peptides raises a shelf-life question nobody has answered.
What is the difference between GLOW, KLOW and the Wolverine stack?
Direct answer
Wolverine is BPC-157 plus TB-500. GLOW adds GHK-Cu, a copper peptide studied for skin. KLOW adds KPV, a small peptide meant to calm swelling, to GLOW. All three are sold as research blends. No published study has tested any of the blends in people. The evidence is only for the single ingredients, and most of it is in animals.
| Blend | What is in it | Typical vial | Sold for |
|---|---|---|---|
| Wolverine | BPC-157 + TB-500 | 10 mg + 10 mg | Injury recovery |
| GLOW | GHK-Cu + BPC-157 + TB-500 | 50 mg + 10 mg + 10 mg (70 mg) | Skin, recovery |
| KLOW | GHK-Cu + KPV + BPC-157 + TB-500 | 50 mg + 10 mg + 10 mg + 10 mg (80 mg) | Repair plus swelling, gut |
The evidence, ingredient by ingredient
| Ingredient | Best evidence in people | Animal evidence | FDA status | July 2026 FDA panel vote |
|---|---|---|---|---|
| TB-500 (a piece of thymosin beta-4) | None for TB-500 itself. The full protein, thymosin beta-4, was tested as eye drops in 1,618 people with dry eye. The biggest study, ARISE-3 with 700 people, missed both of its main goals. It was also tried on pressure sores and leg ulcers, and given into a vein to 30 healthy people in an early safety study. | Healing studies in rats and mice | Not approved | 8 to 6 yes (advice only) |
| GHK-Cu | Two studies in people, and neither beat a cream with nothing in it on anything a doctor measured. In 86 people with leg ulcers, it did no better than the empty cream (1992). In 13 people after laser skin treatment, doctors saw no difference in redness, wrinkles or skin quality. The patients themselves rated their skin better (2006). | Wound and skin studies | Skin care ingredient | Not reviewed |
| BPC-157 | Three small reports from one clinic, with nobody to compare against: knee pain shots (16 patient records looked at afterwards), a painful bladder condition (12) and a safety check of a drip into the vein (2) | Many studies in rats and mice on tendons, gut and blood vessels | Not approved | 8 to 6 yes (advice only) |
| KPV | No study in people of any kind. When FDA staff searched before the July 2026 vote, they found no studies in people, no data on how the body handles it and no side-effect reports. | Gut inflammation and swelling studies in animals | Not approved | 8 to 6 yes (advice only) |
Three things stand out. First, the ingredients are not on the same level, and the blend ads hide that. KPV has never been given to a person, while thymosin beta-4 has been given to thousands. Second, where studies in people exist, they mostly came up empty. In the GHK-Cu leg ulcer study, 86 patients got the copper peptide cream, a silver cream or a cream with nothing in it. The copper peptide did no better than the empty cream (Journal of Vascular Surgery, 1992). A 2006 study after laser skin treatment found doctors saw no difference in redness, wrinkles or skin quality. Only the patients' own ratings favored GHK-Cu (Archives of Facial Plastic Surgery, 2006). Those are real results, and they point away from the product. Third, the FDA's own review of BPC-157 in July 2026 found no good studies in people. It also found products on the market whose lab certificates did not match the label (FDA briefing document). For the full legal picture, including why the panel voted yes anyway, see the FDA peptide status tracker.
Does stacking peptides work?
Direct answer
Nobody knows, because no blend has been studied. Mixing things can add their effects, cancel them out, or change how each one is absorbed and broken down. The only way to know is to test the mix. For GLOW and KLOW, nobody has tested the mix, nobody has checked how long it stays good, and nobody has worked out a dose from data.
The closest thing is a handful of studies in rats and mice that gave BPC-157 and thymosin beta-4 as separate shots in the same experiment. They were never mixed in one syringe. That is a different question.
The shelf-life question
GHK-Cu is bound to copper. Mixed with water, it turns blue and acidic. BPC-157 and TB-500 hold up fine in the bacteriostatic water people usually mix them with. But they break down faster when things turn acidic, and metals like copper speed that up. Nobody has published whether a KLOW vial mixed on day one still holds what the label says on day 28. Sellers do not test it. The FDA review that found mislabeled single peptides did not test blends either. Anyone using these is running their own untested shelf-life experiment.
How long does the Wolverine stack take to work?
Direct answer
No study in people has measured how long the Wolverine stack, or either ingredient, takes to work. In rat tendon studies, the tissue changed over two to four weeks. Users describe anything from a few days to nothing at all. That is what you would expect from an untested product when nobody has checked what is in the vial.
What the calculator and tracker can and cannot do with a blend
Our mixing calculator turns an amount you enter into syringe units for a single compound. With a blend, the label ratio decides how much of each ingredient is in every draw. An 80 mg KLOW vial mixed in 2 mL gives 25 mg/mL of GHK-Cu but only 5 mg/mL of each of the others. So a draw that gives a typical GHK-Cu amount gives five times less of everything else. If you track a blend in the free tracker, enter it as one custom compound and keep the label with the vial.
The honest summary
These blends exist because they sell, not because anyone studied them. Some ingredients look interesting in animals. The blends are unknown in every way that matters: whether they work, how long they keep, what dose to use and whether they are safe. If you want the research on each ingredient, the compound profiles linked above hold every study we could find.
Frequently asked questions
Can you take KLOW and GLOW at the same time?
Everything in GLOW is also in KLOW, so taking both just doubles the shared ingredients for no reason. Neither has a tested dose, so there is no evidence-based answer to any question about combining them.
How long do you stay on GLOW peptide?
No study has tested any length of time. The cycles printed on seller pages do not come from data.
What are the side effects of KLOW peptide?
Nobody has studied that properly. The known worries come from the single ingredients: copper building up from GHK-Cu, reactions where you inject, and a cancer warning because some ingredients help grow new blood vessels in animals.
Do Wolverine peptides actually work?
TB-500 itself has never been studied in people. The full protein it comes from, thymosin beta-4, has: more than 1,600 people in dry eye studies, and the biggest missed both of its main goals. BPC-157 has three small reports from one clinic, with nobody to compare against. In rats and mice, both help healing in many experiments. Whether they work in people is unproven, and where the full protein was properly tested, it did no better than a dummy treatment.
Compound profiles mentioned
- BPC-157Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 31 people given it.Healing & Recovery
- TB-500Preliminary. Studied in people, but no published study has had people take it. 1 registered with no result.Healing & Recovery
- GHK-CuLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 99 people given it.Healing & Recovery
- KPVAnimal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.Healing & Recovery
- KLOW blendLimited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it.Healing & Recovery
- GLOW blendLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 22 people given it.Cosmetic
- Pentadeca ArginateAnimal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, no human study.Healing & Recovery
Sources
- Review of studies2026
FDA evaluation of thymosin beta 4 related bulk drug substances (PCAC, July 2026)
The FDA found no study that gave TB-500 to a person in any way, and no side-effect reports for it in its database. This replaces a consumer health article cited here before under a reworded title, with a claim that went too far: BPC-157 does have a small record in people, fewer than 110 people, none of it from shots under the skin or into muscle.
FDA - Study in people1992
A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers
86 people with leg ulcers: a 0.4% copper peptide cream did no better than a cream with nothing in it, while a silver cream beat both.
Journal of Vascular Surgery - Study in people2006
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
13 people after laser skin treatment: doctors saw no difference in redness, wrinkles or skin quality. The patients rated their overall skin better on GHK-Cu.
Archives of Facial Plastic Surgery - Review of studies2025
BPC-157 in orthopedic and sports medicine: a systematic review
The only evidence in people is one report on a small group, with nobody to compare them against.
HSS Journal - Review of studies2026
FDA briefing document: BPC-157 (PCAC July 2026)
No good studies in people; products found that did not match their labels.
FDA - Review of studies2026
FDA briefing document: KPV-related bulk drug substances (PCAC, July 2026)
No studies in people, no data on how the body handles it and no side-effect reports found for KPV.
FDA - Review of studies2025
BPC-157 literature and patent review
A summary of the animal studies and what they can't tell us.
PubMed Central PMC11859134
Read next
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.